IPO Central

Krsnaa Diagnostics IPO description – Krsnaa Diagnostics is a large and differentiated diagnostic service provider, offering a range of technology-enabled diagnostic services such as imaging (including radiology), pathology/clinical laboratory and tele-radiology services to public and private hospitals, medical colleges and community health centres pan-India. The company is among the fastest growing diagnostic chains in India on parameters such as operating income, operating profit before depreciation, interest and tax (OPBDIT), profit after tax between Fiscal 2017 and Fiscal 2020, and volume of tests conducted between Fiscal 2018 and Fiscal 2020.

The company focuses on the public private partnership (PPP) diagnostics segment and has the largest presence in the diagnostic PPP segment. Its PPP agreements are typically long-term in nature and ensure predictability of revenues from operations. As of 31 December 2020, it has deployed 1,781 diagnostic centres pursuant to PPP agreements with public health agencies. In addition to the PPP segment, it has been growing collaboration with private healthcare providers to operate diagnostic centres within their facilities, and has expanded from operating 12 diagnostic centres, as of FY2018 to 17 diagnostic centres, as of FY2020 and operated 20 such diagnostic centres as of 31 December 2020.

As of 31 December 2020, it operated 1,801 diagnostic centres offering radiology and pathology services in 13 states across India. Its operating model involves diagnostic centres operated under a hospital partnership model. These diagnostic centres are located within existing facilities of public and private hospitals or community health centres, and operated pursuant to arrangements with public health agencies and private healthcare providers.

Promoters of Krsnaa Diagnostics – Rajendra Mutha